ZURICH (Reuters) - Roche Holding AG is likely to extend its $5.7 billion cash bid for U.S. gene decoder Illumina again when its offer expires at midnight on Friday, as the Swiss drugmaker stays true ...

ZURICH, March 20 (Reuters) - - Swiss drugmaker Roche wrote to Illumina investors directly on Tuesday and urged them to accept its $5.7 billion bid, arguing that the U.S. gene decoder faces pressure on ...